EnGen Bio Develops Microbiome Platform with Uri Aideul Hospital

[Asia Economy Reporter Park Jihwan] Ngenbio announced on the 4th that it has signed a strategic partnership (MOU) with Woori Children’s Hospital Foundation for a "microbiome test-based personalized health management curation platform."

The company explained that this business agreement is significant as it is an MOU between Ngenbio, which possesses microbiome analysis technology, and Woori Children’s Hospital, which holds clinical information and clinical verification data for children and adolescents. Both parties plan to establish a standard Korean microbiome database for infants to adolescents and introduce healthcare solutions that can maintain the balance of microbiomes within the body.

Choi Daechul, CEO of Ngenbio, stated, "While oral and gut microbiome research related to pediatric and adolescent diseases and health has been actively conducted overseas, there is a lack of related research results domestically. Through this agreement, we will accumulate clinical microbiome data and develop a standard microbiome database for children and adolescents, enabling its use in developing new disease diagnostic technologies and testing services."

Last year, Ngenbio declared its intention to develop a healthcare big data platform by applying machine learning and artificial intelligence (AI) technologies. The plan includes utilizing next-generation sequencing (NGS)-based cancer gene data, genetic test data from the general public, and microbiome data.

This content was produced with the assistance of AI translation services.